As of May 27
| +0.29 / +4.56%|
The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 16.00, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a +140.60% increase from the last price of 6.65.
The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.